查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854628

血管成形术用气球市场按产品、适应症和最终用户划分 - 全球预测 2025-2032

Angioplasty Balloons Market by Product, Indication, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血管成形术用气球市场规模将达到 81.6 亿美元，复合年增长率为 8.85%。

关键市场统计数据
基准年 2024 41.4亿美元
预计年份：2025年 45.1亿美元
预测年份 2032 81.6亿美元
复合年增长率 (%) 8.85%

本文概述了器械创新、不断发展的临床证据和采购审查如何重新定义血管成形术用气球的战略作用。

血管成形术用气球是经皮心臟病学和周边血管治疗的主要工具，支持常规手术和复杂的重组策略。近年来，技术的进步和不断增长的临床证据已将器械的选择从纯粹的技术选择转变为治疗路径中的策略性环节，影响手术成功率、疗效的持久性和血管的长期通畅性。临床医师在评估球囊时，不仅关注其标称直径和顺应性，还越来越重视药物输送特性、涂层均匀性以及球囊在不同病变形态下的展开行为等辅助特性。

同时，医疗系统和支付方正日益关注手术价值，并将采购重点转向那些临床表现稳定、併发症发生率低、供应链管理精简的医疗器材。不断变化的法规和不断累积的真实世界证据正在重塑人们对标籤检视和上市后监管的预期。这些动态共同作用，为市场环境的微妙变化奠定了基础，在这个变化中，临床差异化、操作相容性和成本控制共同决定医疗器材的最终应用。

药物输送技术的进步、监管机构对实际疗效的重视以及供应链需求如何改变医疗器材的普及应用动态

血管成形球囊领域正经历一系列变革性转变，这些转变正在改变器械的研发、应用和报销模式。首先，药物输送技术的成熟使临床讨论不再局限于机械扩张，而是扩展到针对血管再阻塞生物机制的综合治疗。这项技术变革促使製造商加强对涂层化学、赋形剂选择和输送均匀性的投入，以提升临床疗效。其次，监管机构对真实世界数据和上市后监测的重视提高了长期安全性和有效性监测的标准，促使供应商将证据产生纳入产品上市策略。

第三，供应链韧性和成本透明度正成为医疗系统运作的优先事项，这加速了人们对供应商整合、标准化器材配方和大量采购合约的关注。第四，诸如结合辅助性切除术和影像引导病变操作的混合方法等手术创新，提高了器械在不同治疗流程中的相容性。总而言之，这些转变正在推动一个更一体化、主导且系统化的市场，其中临床效用、操作相容性和生命週期支援决定着器械的长期应用轨迹。

评估2025年关税政策对供应链调整、采购决策和采购行动的影响，以及这些调整和行动对设备可用性和成本结构的影响。

2025年的关税政策变化将为血管成形术用气球的製造商、经销商和采购商带来新的考量，增加本已复杂的供应链的成本和营运难度。某些类别医疗设备进口关税的提高迫使许多供应商重新评估其生产地点、筹资策略以及与全球合作伙伴的合约条款。为此，一些製造商探索了近岸外包方案，实现了零件采购多元化，并重新谈判了供应商合同，以缓解利润压力，并维持对临床客户的稳定供应。

医疗系统和采购集团的应对措施包括加快供应商整合，并寻求更透明的土地成本模型来预测手术成本。一些机构优先选择提供价格保护和库存支援的合同，以缓解短期波动。关税调整也促使人们重新关注手术设备标准化，以减少库存单位的复杂性和管理负担。重要的是，这些调整不仅仅是财务方面的；它们还影响了商业化时间表、产品上市顺序和策略伙伴关係，因为它们需要在监管合规性、生产灵活性和维持临床可用性之间取得平衡。

按产品类型、临床适应症和医疗保健环境进行细分，突显了血管成形术用气球在临床、采购和商业化方面的重要性。

我们的细分市场分析揭示了产品设计、临床适应症和终端用户环境如何影响血管成形术用气球的竞争格局。依产品类型划分，我们提供药物涂层球囊和普通球囊，每种球囊的实证依据、采购标准和临床应用模式各不相同。药物涂层技术在关注血管再阻塞风险时尤其重要，而普通球囊则适用于简单病变以及优先考虑成本效益的医疗机构。按适应症划分，我们检视了冠状动脉和周边血管的市场，其中周边血管类别进一步细分为颈动脉、髂动脉、下肢和肾动脉。这些不同的解剖靶点需要客製化尺寸、顺应性和输送特性，因此，针对特定病变的设计考虑和操作者培训至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 药物涂层球囊在周边动脉疾病治疗的应用日益广泛，可改善临床疗效。
  • 开发具有增强的生物相容性和径向强度的先进球囊材料，用于复杂病变
  • 对能够在迂曲的冠状动脉中进行复杂病变导航的低轮廓输送系统的需求日益增长
  • 将血管内影像技术与血管成形术用气球结合，以实现精确的病变测量和治疗指导。
  • 新一代药物释放型球囊获得监管部门核准，该球囊具有可控释放特性，可最大限度血管再阻塞
  • 微创血管成形术的推广将推动亚太地区和新兴拉丁美洲市场的成长。
  • 结合抗增殖药物洗脱和血管支架功能的双重治疗球囊的技术进步
  • 医疗设备创新者与研究机构之间的策略合作加速了血管成形术用气球的创新。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章血管成形术用气球市场（依产品分类）

  • 药物涂层球囊
  • 普通气球

第九章血管成形术用气球市场（依适应症划分）

  • 冠状动脉
  • 邻里
    • 颈动脉
    • 髂骨
    • 下肢
    • 肾

第十章血管成形术用气球市场（依最终用户划分）

  • 门诊手术中心
  • 心臟中心
  • 医院
  • 专科诊所

第十一章血管成形术用气球市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章血管成形术用气球市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国血管成形术用气球市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Medtronic plc
    • Becton, Dickinson and Company
    • Terumo Corporation
    • Cordis Corporation
    • Cook Medical LLC
    • Nipro Corporation
    • OrbusNeich Medical Group Holdings Limited
    • LeMaitre Vascular, Inc.
Product Code: MRR-957C47F90693

The Angioplasty Balloons Market is projected to grow by USD 8.16 billion at a CAGR of 8.85% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.14 billion
Estimated Year [2025] USD 4.51 billion
Forecast Year [2032] USD 8.16 billion
CAGR (%) 8.85%

A concise framing of how device innovation, clinical evidence evolution, and procurement scrutiny are redefining the strategic role of angioplasty balloons

Angioplasty balloons remain central to percutaneous interventional cardiology and peripheral vascular care, underpinning both routine procedures and complex revascularization strategies. Over recent years, technological refinement and iterative clinical evidence have elevated device selection from a purely technical choice to a strategic component of care pathways, influencing procedural success, durability of outcomes, and long-term vessel patency. Clinicians increasingly evaluate balloons not only on nominal diameter and compliance but on adjunctive attributes such as drug delivery profile, coating uniformity, and deployment behavior under varied lesion morphologies.

Concurrently, health systems and payers are intensifying scrutiny of procedure value, which has shifted procurement conversations toward devices that demonstrate consistent clinical performance, reduce complication rates, and streamline supply chain management. Regulatory evolution and the accumulation of real-world evidence are reshaping labeling and post-market surveillance expectations, while centers of excellence focus on protocol standardization to reduce variability in outcomes. Together, these dynamics set the stage for a nuanced market environment in which clinical differentiation, operational compatibility, and cost containment coalesce to determine device adoption.

How advancements in drug-delivery technology, regulatory emphasis on real-world outcomes, and supply chain demands are transforming device adoption dynamics

The angioplasty balloon landscape is being reshaped by a series of transformative shifts that are collectively altering how devices are developed, adopted, and reimbursed. First, the maturation of drug delivery technologies has broadened clinical conversations from purely mechanical dilation to integrated therapy that addresses restenosis biology. This technological pivot has prompted manufacturers to invest in coating chemistry, excipient selection, and delivery uniformity to differentiate clinical performance. Second, regulatory emphasis on real-world data and post-market surveillance has increased the bar for longitudinal safety and effectiveness monitoring, motivating vendors to build evidence generation into product launch strategies.

Third, supply chain resilience and cost transparency have emerged as operational priorities for health systems, accelerating interest in vendor consolidation, standardized device formularies, and bundled procurement agreements. Fourth, procedural innovation-such as hybrid approaches that combine adjunctive atherectomy or imaging-guided lesion preparation-has elevated the importance of device compatibility across diverse treatment workflows. Taken together, these shifts are driving a more integrated, evidence-driven, and system-aware market where clinical utility, operational fit, and lifecycle support determine long-term adoption trajectories.

Assessment of the 2025 tariff-driven recalibration of supply chains, sourcing decisions, and procurement behavior affecting device availability and cost structures

Tariff policy changes in 2025 imposed new considerations for manufacturers, distributors, and purchasers of angioplasty balloons, introducing cost and operational complexity into already intricate supply chains. Increased import levies on certain classes of medical devices prompted many suppliers to reassess production footprints, sourcing strategies, and contractual terms with global partners. In response, several manufacturers explored nearshoring options, diversified component sourcing, and renegotiated supplier contracts to mitigate margin pressure and maintain stable supply to clinical customers.

Health systems and purchasing groups responded by accelerating vendor rationalization and by seeking more transparent landed-cost models to predict procedural expenses. Some institutions prioritized agreements that provided price protection and inventory support to blunt short-term volatility. The tariff-induced recalibration also spurred a renewed focus on device standardization across procedural suites to reduce SKU complexity and administrative burden. Importantly, these adjustments were not solely financial; they influenced commercialization timelines, product launch sequencing, and strategic partnerships as firms balanced regulatory compliance, manufacturing flexibility, and the imperative to sustain clinical availability.

How product type, clinical indication, and care setting segmentation reveal distinct clinical, procurement, and commercialization imperatives for angioplasty balloons

Segmentation insight highlights how product design, clinical indication, and end-user environment collectively shape the competitive dynamics for angioplasty balloons. Based on Product, market is studied across Drug Coated Balloon and Plain Balloon, and that distinction drives different evidence needs, purchasing criteria, and clinical adoption patterns; drug-coated technologies command particular attention where restenosis risk is a central concern, whereas plain balloons retain importance for simpler lesions and for centers prioritizing procedural cost efficiency. Based on Indication, market is studied across Coronary and Peripheral, with the Peripheral category further studied across Carotid, Iliac, Lower Limb, and Renal; these divergent anatomical targets require tailored sizing, compliance characteristics, and delivery profiles, elevating the role of lesion-specific design considerations and operator training.

Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, Hospitals, and Specialty Clinics, and the purchasing priorities across these settings vary markedly. Ambulatory surgical centers emphasize throughput, predictable inventory, and cost-effective device selection, while cardiac centers and hospitals balance high-acuity capability with multi-disciplinary procurement processes that factor in clinical preference, support services, and educational partnerships. Specialty clinics often prioritize niche devices optimized for targeted peripheral interventions and may favor vendors that can provide focused clinical training and flexible procurement terms. Recognizing these intersecting segmentation lenses is essential for product positioning and channel strategy.

Regional adoption drivers and procurement behaviors across the Americas, EMEA, and Asia-Pacific that determine clinical uptake and commercialization pathways

Regional dynamics demonstrate how reimbursement frameworks, clinical practice patterns, and regulatory climates interact to shape demand and adoption pathways across geographies. In the Americas, clinical networks and device distributors play a dominant role in establishing formularies and in aligning device selection with institutional protocols; a mature interventional cardiology infrastructure supports rapid assimilation of incremental device innovations when supported by robust clinical evidence and clear procurement value propositions. In Europe, Middle East & Africa, divergent regulatory environments and heterogeneous reimbursement mechanisms create a patchwork of adoption timelines, with some national systems emphasizing centralized procurement and others allowing more localized decision-making, which in turn affects the pace at which new technologies are adopted.

In Asia-Pacific, rapid investments in vascular care capacity combined with growing local manufacturing capabilities are reshaping competitive dynamics; several markets within the region are prioritizing technology transfer and local regulatory approvals to reduce import dependencies. Across all regions, cross-border partnerships, regional clinical investigators, and localized evidence generation are decisive factors that influence how quickly clinicians incorporate new balloon technologies into treatment algorithms and how purchasing organizations evaluate supplier commitments to training and supply continuity.

Insights into how clinical evidence, manufacturing partnerships, and differentiated commercial capabilities determine competitive positioning among device manufacturers

Competitive dynamics among manufacturers reflect a balance between technological differentiation, clinical evidence generation, and commercial execution. Leading firms invest in coating science, deployment precision, and clinical trial programs to substantiate claims of improved vessel patency or reduced need for repeat interventions. At the same time, a cohort of agile, smaller manufacturers focuses on niche indications or cost-competitive plain balloon offerings that serve high-volume, price-sensitive channels. Strategic alliances between device makers and contract manufacturers have also become more common as firms seek to scale production while preserving capital for R&D and post-market studies.

Commercial capabilities-including clinician education programs, local regulatory expertise, and integrated supply solutions-shape market access nearly as much as product features in many settings. Manufacturers that align clinical KOL engagement with comprehensive real-world outcome tracking tend to gain sustained preference among large health systems. Moreover, companies that offer logistical flexibility, training partnerships, and responsive field support can mitigate barriers to switching and can accelerate adoption in settings where procedural volume and institutional inertia otherwise slow uptake.

Practical strategic actions that synchronize evidence generation, supply chain resilience, and commercial propositions to enhance adoption and mitigate operational risk

Industry leaders should prioritize a set of pragmatic actions that align clinical validation, operational resilience, and commercial clarity to capture sustainable advantage. Invest in targeted real-world evidence programs that complement randomized studies and demonstrate device performance across routine practice environments; such data supports adoption conversations with both clinicians and payers. Simultaneously, strengthen supply chain flexibility by diversifying component sources, exploring regional manufacturing options, and negotiating contractual provisions that reduce exposure to tariff and logistics shocks. These steps will protect availability while preserving margin stability.

Commercially, refine value propositions by linking clinical outcomes to total procedural cost and care pathway efficiency, and design pricing strategies that reflect predictable landed costs for institutional buyers. Enhance customer intimacy through training initiatives, field support, and clinician-led education to lower switching barriers. Finally, pursue selective partnerships with outpatient centers and specialty clinics to broaden route-to-market channels and to pilot new procedural protocols that can later scale into larger hospital systems. Together, these actions align product innovation with the operational needs of purchasers and the clinical priorities of users.

A rigorous multi-source research approach integrating clinical literature review, regulatory analysis, expert interviews, and supply chain assessment for robust insights

The research for this analysis combined a structured review of peer-reviewed clinical literature, regulatory filings, and publicly available guidance with structured expert interviews and primary qualitative outreach to device manufacturers, clinician leaders, and procurement professionals. Clinical evidence appraisal prioritized randomized trials, registry data, and carefully controlled observational studies to understand performance characteristics across device types and anatomical indications. Regulatory documentation and post-market safety notices were examined to identify trends in labeling, adverse event reporting, and surveillance expectations that affect commercial strategy.

Primary qualitative research included in-depth interviews with interventional cardiologists, peripheral vascular specialists, procurement directors, and device commercialization experts to surface practical considerations around device selection, training needs, and inventory management. Supply chain assessment drew on supplier disclosures, manufacturing footprint analyses, and industry commentary to map sourcing vulnerabilities and response strategies. Finally, cross-validation was performed by triangulating qualitative inputs with the clinical literature and regulatory records to ensure findings are robust, actionable, and reflective of current industry realities.

Synthesis of innovation, evidence demands, and supply resilience as the primary forces shaping strategic decisions in the angioplasty balloon domain

In conclusion, the angioplasty balloon landscape is evolving from a focus on mechanical dilation to a broader paradigm that integrates drug delivery, procedural compatibility, and operational reliability. This evolution is driven by advances in coating technologies, heightened expectations for real-world evidence, and increasing procurement sophistication among health systems. Tariff shifts and supply chain pressures have injected urgency into manufacturing and sourcing decisions, prompting manufacturers to reconsider production geographies and to strengthen commercial terms with large institutional buyers. Segmentation across product type, anatomical indication, and end-user setting underscores the need for tailored product designs and channel strategies that reflect distinct clinical and purchasing priorities.

Regional dynamics further complicate the pathway to adoption, with differing regulatory and reimbursement landscapes requiring localized evidence and market approaches. Competitive differentiation now hinges as much on evidence, clinician engagement, and supply assurance as it does on incremental device features. For decision-makers, the imperative is clear: align innovation with demonstrable clinical impact, secure resilient supply and transparent pricing, and invest in clinician and purchaser partnerships that accelerate safe, effective adoption of new device technologies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of drug-coated balloons for peripheral arterial disease treatment improving clinical outcomes
  • 5.2. Development of advanced balloon materials with enhanced biocompatibility and radial strength for complex lesions
  • 5.3. Rising demand for low-profile delivery systems enabling complex lesion navigation in tortuous coronary arteries
  • 5.4. Integration of intravascular imaging modalities with angioplasty balloons for accurate lesion measurement and therapy guidance
  • 5.5. Regulatory approvals for next-generation drug-eluting balloons with controlled release profiles to minimize restenosis
  • 5.6. Expansion of minimally invasive angioplasty procedures driving market growth in emerging Asia-Pacific and Latin America regions
  • 5.7. Technological advancements in dual therapy balloons combining antiproliferative drug elution and vessel scaffolding functionalities
  • 5.8. Strategic collaborations between medical device innovators and research institutions accelerating angioplasty balloon innovation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Angioplasty Balloons Market, by Product

  • 8.1. Drug Coated Balloon
  • 8.2. Plain Balloon

9. Angioplasty Balloons Market, by Indication

  • 9.1. Coronary
  • 9.2. Peripheral
    • 9.2.1. Carotid
    • 9.2.2. Iliac
    • 9.2.3. Lower Limb
    • 9.2.4. Renal

10. Angioplasty Balloons Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Angioplasty Balloons Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Angioplasty Balloons Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Angioplasty Balloons Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Boston Scientific Corporation
    • 14.3.2. Abbott Laboratories
    • 14.3.3. Medtronic plc
    • 14.3.4. Becton, Dickinson and Company
    • 14.3.5. Terumo Corporation
    • 14.3.6. Cordis Corporation
    • 14.3.7. Cook Medical LLC
    • 14.3.8. Nipro Corporation
    • 14.3.9. OrbusNeich Medical Group Holdings Limited
    • 14.3.10. LeMaitre Vascular, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANGIOPLASTY BALLOONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 91. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 102. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 112. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 142. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 151. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 152. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 172. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 173. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 174. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 182. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 183. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 184. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 185. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 186. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 187. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. GCC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 202. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 203. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 204. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 205. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 206. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 207. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. BRICS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 212. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 213. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 214. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 215. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 216. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 217. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. G7 ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 222. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 223. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 224. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 225. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 226. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 227. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. NATO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 237. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 243. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 245. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 249. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 251. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 253. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 257. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 259. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 261. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 273. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 275. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 277. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 281. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 283. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 285. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 289. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 291. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 293. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 297. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 299. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 301. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 304. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 305. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 306. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 307. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 308. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 309. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 312. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 313. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 314. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 315. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 316. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 317. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 320. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 321. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 322. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 323. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 324. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 325. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 328. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 329. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 330. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 331. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 332. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 333. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 336. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 337. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 338. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 339. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 340. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 341. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 344. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 345. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 346. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 347. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 348. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 349. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 350. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE